| Authors: |
Sane RS; Clinical Pharmacology, Genentech, Inc., South San Francisco, California. Electronic address: sane.rucha@gene.com., Mitra P; Department of Clinical Pharmacology & Nonclinical Safety Sciences, Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut., Lai Y; Drug Metabolism, Gilead Sciences, Inc, Foster City, California., Li CY; Department of Pharmacokinetics and Drug Metabolism, Amgen Inc, South San Francisco, California., Shen H; Department of Drug Metabolism and Pharmacokinetics, Bristol Myers Squibb Research and Development, Princeton, New Jersey., Tohyama K; Takeda Pharmaceutical Company Limited, Fujisawa, Japan., Costales C; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Research and Development, Pfizer Inc., Groton, Connecticut., Salphati L; Departments of Drug Metabolism and Pharmacokinetics, Genentech, Inc, South San Francisco, California., Mahar KM; Clinical Pharmacology Modeling and Simulation, GlaxoSmithKline Research and Development, Collegeville, Pennsylvania., Bow DAJ; Quantitative, Translational and ADME Sciences, AbbVie Inc, North Chicago, Illinois., Vergis JM; IQ Secretariat, Faegre Drinker Biddle & Reath LLP, Washington, District of Columbia., Brumm J; Nonclinical Biostatistics, Genentech, Inc, South San Francisco, California., Taskar K; DMPK Modeling, IVIVT, Research, GSK, Stevenage, United Kingdom., Chanteux H; Quantitative Clinical Pharmacology, Early Clinical Development & Translational Sciences, UCB Biopharma SRL, Braine-L'Alleud, Belgium., Fang Z; NCE Drug Metabolism and Pharmacokinetics, the Healthcare Business of Merck KGaA, Darmstadt, Germany., Liang X; Drug Metabolism, Gilead Sciences, Inc, Foster City, California., Park SH; Preclinical Sciences and Translational Safety, Johnson & Johnson, Spring House, Pennsylvania., Hanna I; Pharmacokinetic Sciences, Novartis Institutes for Biomedical Research, East Hanover, New Jersey., Thakkar N; Clinical Pharmacology Modeling and Simulation, GlaxoSmithKline Research and Development, Collegeville, Pennsylvania., Chu X; Department of Pharmacokinetics, Dynamics, Metabolism, and Bioanalytics, Merck & Co, Inc, Rahway, New Jersey., Hop CECA; Departments of Drug Metabolism and Pharmacokinetics, Genentech, Inc, South San Francisco, California., Rollison HE; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Taub ME; Department of Clinical Pharmacology & Nonclinical Safety Sciences, Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut., Kimoto E; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Research and Development, Pfizer Inc., Groton, Connecticut., Fenner KS; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Xu C; Pharmacokinetics, Dynamics, and Metabolism, Translational Medicine and Early Development, Sanofi US, Bridgewater, New Jersey., Hillgren KM; Investigative Drug Disposition, Lilly Research Laboratories, Eli Lilly Inc, Indianapolis, Indiana. |
